Search results
FATE To End Janssen Deal and Prioritize Pipeline Development
Zacks via Yahoo Finance· 1 year agoFate Therapeutics, Inc. FATE announced that it has declined a proposal from Janssen Biotech, Inc., a...
Illumina (ILMN) Extends Partnership to Advance Cancer Test
Zacks via Yahoo Finance· 4 months agoIllumina, Inc. ILMN recently entered into an agreement with Janssen Research & Development, LLC...
Biotech Stock Roundup: HZNP Surges on AMGN Offer, TRDA Gains on VRTX Deal & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in the spotlight this week courtesy of acquisition news and strategic...
Protagonist (PTGX) Up on Positive Results From FRONTIER Study
Zacks via Yahoo Finance· 1 year agoShares of Protagonist Therapeutics, Inc. PTGX surged 51.91% on Mar 7 after the company announced...
From free Stanford courses at Northrop Grumman to revamped internships at Salesforce, here’s how 9...
Fortune via Yahoo Finance· 11 months agoOpenAI’s November release of its ChatGPT platform catapulted artificial intelligence, and more...
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
Investor's Business Daily· 1 year agoJohnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to...
LAVA (LVTX) Up on J&J's (JNJ) Cancer Study Candidate Selection
Zacks via Yahoo Finance· 11 months agoLAVA Therapeutics’ LVTX shares were up almost 27% on Jun 1, after market hours. This followed soon...
Why Is Alkermes (ALKS) Down 9% Since Last Earnings Report?
Zacks via Yahoo Finance· 9 months agoIt has been about a month since the last earnings report for Alkermes (ALKS). Shares have lost about...
Emergent's (EBS) Q2 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoEmergent Biosolutions Inc. EBS reported second-quarter 2022 adjusted loss of 86 cents per share,...
Morphic Holding Inc (MORF) Reports Q3 2023 Loss of $36.2 Million, Ends Quarter with $725. ...
GuruFocus.com via Yahoo Finance· 6 months agoMorphic Holding Inc (NASDAQ:MORF) reported a net loss of $36.2 million for Q3 2023, compared to a...